SUMMERS, R. W.; ELLIOTT, D. E.; URBAN, J. F., et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005, roč. 128, čís. 4, s. 825–32. Dostupné online. PMID15825065.
HSU, S. J.; TSENG, P. H.; CHEN, P. J. Trichuris suis therapy for ulcerative colitis: nonresponsive patients may need anti-helminth therapy. Gastroenterology.. 2005, roč. 129, čís. 2, s. 768–9; author reply 769. Dostupné online. PMID16083738.
HEPWORTH, M. R.; HAMELMANN, E.; LUCIUS, R., et al. Looking into the future of Trichuris suis therapy. J Allergy Clin Immunol.. 2010, roč. 125, čís. 3, s. 767–8; author reply 768-9. Dostupné online. PMID20153034.
doi.org
dx.doi.org
Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR, Welfare MR. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. October 2004, s. 1479–84. DOI10.1136/gut.2003.024828. PMID15361498.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Andersen V, Olsen A, Carbonnel F, Tjønneland A, Vogel U. Diet and risk of inflammatory bowel disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. March 2012, s. 185–94. DOI10.1016/j.dld.2011.10.001. PMID22055893.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Judaki A et al. Evaluation of dairy allergy among ulcerative colitis patients.. Bioinformation. 2014. DOI10.6026/97320630010693. PMID25512686.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
RAITHEL, M; WINTERKAMP, S; WEIDENHILLER, M; MÜLLER, S; HAHN, EG. Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis.. TInt J Colorectal Dis. 2007, s. 833-839. DOI10.1007/s00384-006-0120-y. PMID16944185.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury.. BMC Immunology. March 2007. DOI10.1186/1471-2172-8-5. PMID17397543.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
nih.gov
ncbi.nlm.nih.gov
Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR, Welfare MR. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. October 2004, s. 1479–84. DOI10.1136/gut.2003.024828. PMID15361498.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Andersen V, Olsen A, Carbonnel F, Tjønneland A, Vogel U. Diet and risk of inflammatory bowel disease. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. March 2012, s. 185–94. DOI10.1016/j.dld.2011.10.001. PMID22055893.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Judaki A et al. Evaluation of dairy allergy among ulcerative colitis patients.. Bioinformation. 2014. DOI10.6026/97320630010693. PMID25512686.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
RAITHEL, M; WINTERKAMP, S; WEIDENHILLER, M; MÜLLER, S; HAHN, EG. Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis.. TInt J Colorectal Dis. 2007, s. 833-839. DOI10.1007/s00384-006-0120-y. PMID16944185.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
DHANESHWAR, S; GAUTAM, H. Exploring novel colon-targeting antihistaminic prodrug for colitis.. J Physiol Pharmacol. Aug 2012, s. 327-337. PMID23070081.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Del Pinto R, Pietropaoli D, Chandar AK, Ferri C, Cominelli F. Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis.. Inflamm Bowel Dis. April 2015. PMID26348447.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury.. BMC Immunology. March 2007. DOI10.1186/1471-2172-8-5. PMID17397543.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Hlavaty T, Krajcovicova A, Payer J. Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much?. J Crohns Colitis. Feb 2015, s. 198-209. PMID26046136.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
SUMMERS, R. W.; ELLIOTT, D. E.; URBAN, J. F., et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005, roč. 128, čís. 4, s. 825–32. Dostupné online. PMID15825065.
YAZDANBAKHSH, M.; KREMSNER, P. G.; VAN REE, R. Allergy, parasites, and the hygiene hypothesis. Science. 2002, roč. 296, čís. 5567, s. 490–4. PMID11964470.
HSU, S. J.; TSENG, P. H.; CHEN, P. J. Trichuris suis therapy for ulcerative colitis: nonresponsive patients may need anti-helminth therapy. Gastroenterology.. 2005, roč. 129, čís. 2, s. 768–9; author reply 769. Dostupné online. PMID16083738.
HEPWORTH, M. R.; HAMELMANN, E.; LUCIUS, R., et al. Looking into the future of Trichuris suis therapy. J Allergy Clin Immunol.. 2010, roč. 125, čís. 3, s. 767–8; author reply 768-9. Dostupné online. PMID20153034.
